UK review targets widespread overprescribing of medicines
The UK government has shown a willingness to take action to prevent medicines being prescribed unnecessarily in England.
A government-commissioned review into overprescribing has been published, revealing that 10% of the volume of prescription items dispensed through primary care in England are either inappropriate for patients’ circumstances and wishes, or could be better served with alternative treatments.
"This is an incredibly important review which will have a lasting impact on people’s lives and improve the way medicines are prescribed"It has also been revealed that 15% of people take five or more medicines a day, increasing the risk of adverse effects, with around one in five hospital admissions in people aged 65 years and over caused by negative impacts from medicines.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
More on this story...
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze